Piguet AC - Search Results

1

Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.

Wang L, Piguet AC, Schmidt K, Tordjmann T, Dufour JF. Wang L, et al. Among authors: piguet ac. Hepatology. 2005 Jun;41(6):1241-51. doi: 10.1002/hep.20697. Hepatology. 2005. PMID: 15861431

2

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.

Semela D, Piguet AC, Kolev M, Schmitter K, Hlushchuk R, Djonov V, Stoupis C, Dufour JF. Semela D, et al. Among authors: piguet ac. J Hepatol. 2007 May;46(5):840-8. doi: 10.1016/j.jhep.2006.11.021. Epub 2007 Jan 17. J Hepatol. 2007. PMID: 17321636

3

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma.

Piguet AC, Semela D, Keogh A, Wilkens L, Stroka D, Stoupis C, St-Pierre MV, Dufour JF. Piguet AC, et al. J Hepatol. 2008 Jul;49(1):78-87. doi: 10.1016/j.jhep.2008.03.024. Epub 2008 Apr 28. J Hepatol. 2008. PMID: 18486258

4

Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma.

Martin J, Magnino F, Schmidt K, Piguet AC, Lee JS, Semela D, St-Pierre MV, Ziemiecki A, Cassio D, Brenner C, Thorgeirsson SS, Dufour JF. Martin J, et al. Among authors: piguet ac. Gastroenterology. 2006 Jun;130(7):2179-88. doi: 10.1053/j.gastro.2006.03.024. Gastroenterology. 2006. PMID: 16762638 Free PMC article.

5

PI(3)K/PTEN/AKT pathway.

Piguet AC, Dufour JF. Piguet AC, et al. J Hepatol. 2011 Jun;54(6):1317-9. doi: 10.1016/j.jhep.2010.12.013. Epub 2010 Dec 17. J Hepatol. 2011. PMID: 21168457 Free article. No abstract available.

6

Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.

Piguet AC, Majumder S, Maheshwari U, Manjunathan R, Saran U, Chatterjee S, Dufour JF. Piguet AC, et al. Clin Sci (Lond). 2014 Jun;126(11):775-84. doi: 10.1042/CS20130081. Clin Sci (Lond). 2014. PMID: 24283268

7

Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis.

Piguet AC, Saran U, Simillion C, Keller I, Terracciano L, Reeves HL, Dufour JF. Piguet AC, et al. J Hepatol. 2015 Jun;62(6):1296-303. doi: 10.1016/j.jhep.2015.01.017. Epub 2015 Jan 23. J Hepatol. 2015. PMID: 25623824 Free article.

8

PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.

Kachaylo E, Tschuor C, Calo N, Borgeaud N, Ungethüm U, Limani P, Piguet AC, Dufour JF, Foti M, Graf R, Clavien PA, Humar B. Kachaylo E, et al. Among authors: piguet ac. Hepatology. 2017 Sep;66(3):908-921. doi: 10.1002/hep.29226. Epub 2017 Jul 20. Hepatology. 2017. PMID: 28437835

9

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2.

Roth P, Hammer C, Piguet AC, Ledermann M, Dufour JF, Waelti E. Roth P, et al. Among authors: piguet ac. J Drug Target. 2007 Nov;15(9):623-31. doi: 10.1080/10611860701502723. J Drug Target. 2007. PMID: 17968716

10

Targeting vessels to treat hepatocellular carcinoma.

Romanque P, Piguet AC, Dufour JF. Romanque P, et al. Among authors: piguet ac. Clin Sci (Lond). 2008 Apr;114(7):467-77. doi: 10.1042/CS20070310. Clin Sci (Lond). 2008. PMID: 18302534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters